Chronic lymphocytic leukemia

Oncologist

Volumn 4, Issue 5, 1999, Pages 352-369

  Kalil, Nelson ^a   Cheson, Bruce D ^b,c  

^a Cancer Therapy Evaluation Program   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c Cancer Therapy and Evaluation Program   (United States)

Author keywords

B cell malignancies; Biology; Chronic lymphocytic leukemia; Chronic lymphoproliferative disorders; CLL; CLL etiology; Cytogenetics; Diagnosis; Treatment

Indexed keywords

CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; PENTOSTATIN; PREDNISONE;

ARTICLE; CANCER STAGING; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL PROTOCOL; CLINICAL TRIAL; CYTOGENETICS; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; HUMAN; NAUSEA; OSTEOPENIA; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT PLANNING; VOMITING;

EID: 0032707533     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.4-5-352     Document Type: Article

References (15)

1. Rozman C, Montserrat E. Current concepts: chronic lymphocytic leukemia. N Engl J Med 1995;333:1052-1057.
2. Linet MS, Blattner WA. The epidemiology of chronic lymphocytic leukemia. In: Pollack A, Catovsky D, eds. Chronic Lymphocytic Leukemia. Switzerland: Harwood Academic Publishers, 1988;11.
3. Call TG, Phyliky RL, Noel P et al. Incidence of chronic lymphocytic leukemia in Olmstead County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis. Mayo Clin Proc 1994;69:323-328.
4. Molica S, Brugiatelli M, Callea V et al. Comparison of younger versus older B-cell chronic lymphocytic leukemia patients for clinical presentation and prognosis. A retrospective study of 53 cases. Eur J Haematol 1994;52:216-221.
5. Landis SH, Murray T, Bolden S et al. Cancer Statistics. CA Cancer J Clin 1998;48:6-29.
6. Linet MS, Cartwright RA. Chronic lymphocytic leukemia: epidemiology and etiologic findings. Nouv Rev Fr Hematol 1988;30:353-357.
7. Montserrat E, Gomis F, Vallespi T et al. Presenting features and prognosis of chronic lymphocytic leukemia in young adults. Blood 1991;78:1545-1551.
8. Kwong YL, Wong KF, Chan LC et al. The spectrum of lymphoproliferative disorders in Chinese people. An analysis of 64 cases. Cancer 1994;74:174-181.
9. Catovsky D, Yuille M, Houlston R. The search for genetic clues. Hematol Cell Ther 1997;39:S53-S102.
10. Horwitz M, Goode EL, Jarvik GP. Anticipation in familial leukemia. Am J Hum Genet 1996;59:990-998.
11. Brok-Simoni F, Rechavi G, Katzir N et al. Chronic lymphocytic leukemia in twin sisters: monozygous but not identical. Lancet 1987;1:329-330.
12. Blattner WA, Dean JH, Fraumeni JF. Familial lymphoproliferative malignancy: clinical and laboratory follow-up. Ann Intern Med 1979;90:943-944.
13. Jones HP, Whitetaker JA. Chronic lymphatic leukemia: an investigation of HLA antigen frequencies and white cell differentiation counts in patients, relatives and controls. Leuk Res 1991;15:543-549.
14. Cuttner J. Increased incidence of hematological malignancies in first-degree relatives of patients with chronic lymphocytic leukemia. Cancer Invest 1992;10:103-109.
15. Conley CL, Misiti J, Laster AJ. Genetic factors predisposing to chronic lymphocytic leukemia and to autoimmune disease. Medicine 1980;5:323-334.